On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial. On Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE:
An unprecedented 60% of patients remain alive without disease progression after five yearsUpdated results show continued 81% reduction in risk of progression or death and 94% reduction in progression of brain metastases
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history.